NVS ファイナンス： Novartis AG AI分析



財務状況

NVS 財務

Novartis AG

$150.45

0%

$0

終値： May 20, 16:00:00 GMT-4

$150.5

0.03%

$0.05

アフターマーケット：May 20, 20:00:00 GMT-4

概要予測収入配当財務状況

主要データ

前終値

$150.44

始値

$150.95

当日レンジ

$150.23 - $151.76

52週レンジ

$104.93 - $170.46

取引高

1.3M

平均取引高

2.2M

配当利回り

1株当たり利益(TTM)

7.15

時価総額

$288.7B

Novartis AGとは何ですか？

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,267 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

特徴

Markets

News

利用規約プライバシーポリシー

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
収入	56,256	13,511	13,860	14,358	14,527	13,585
収益成長率（YoY）	6%	-1%	2%	9%	13%	12%
収益のコスト	13,834	3,438	3,542	3,535	3,319	3,224
売上総利益	42,422	10,073	10,318	10,823	11,208	10,361
販売、一般および管理	13,318	3,137	3,436	3,304	3,441	3,057
研究開発	10,697	2,704	2,763	2,677	2,553	2,302
運営費用	24,523	5,964	6,268	6,238	6,053	5,575
その他の非営業収入（費用）	-73	4	-57	-7	-13	46
税引前利益	15,784	3,839	3,218	4,196	4,531	4,407
所得税費	2,270	683	814	266	507	798
純利益	13,534	3,156	2,409	3,928	4,041	3,606
純利益成長率	5%	-12%	-15%	23%	24%	34%
流通済み株式数（希薄化後）	1,916	1,916	1,937	1,940	1,960	1,979
株式変動（前年比）	-3%	-3%	-4%	-4%	-4%	-4%
EPS（希薄化）	7.06	1.65	1.24	2.02	2.06	1.82
EPS成長率	9%	-9%	-11%	28.99%	30%	39%
フリーキャッシュフロー	15,962	2,869	1,247	5,740	6,106	2,151
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	75.4%	74.55%	74.44%	75.37%	77.15%	76.26%
営業利益率	31.81%	30.41%	29.22%	31.93%	35.48%	35.23%
利益率	24.05%	23.35%	17.38%	27.35%	27.81%	26.54%
フリーキャッシュフロー利益率	28.37%	21.23%	8.99%	39.97%	42.03%	15.83%
EBITDA	23,298	5,337	5,601	5,949	6,411	5,940
EBITDAマージン	41.41%	39.5%	40.41%	41.43%	44.13%	43.72%
D&A による EBITDA	5,399	1,228	1,551	1,364	1,256	1,154
営業利益	17,899	4,109	4,050	4,585	5,155	4,786
営業利益率	31.81%	30.41%	29.22%	31.93%	35.48%	35.23%
実効税率	14.38%	17.79%	25.29%	6.33%	11.18%	18.1%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

収入

56,256

13,511

13,860

14,358

14,527

13,585

収益成長率（YoY）

-1%

13%

12%

収益のコスト

13,834

3,438

3,542

3,535

3,319

3,224

売上総利益

42,422

10,073

10,318

10,823

11,208

10,361

販売、一般および管理

13,318

3,137

3,436

3,304

3,441

3,057

研究開発

10,697

2,704

2,763

2,677

2,553

2,302

運営費用

24,523

5,964

6,268

6,238

6,053

5,575

その他の非営業収入（費用）

-73

-57

-7

-13

税引前利益

15,784

3,839

3,218

4,196

4,531

4,407

所得税費

2,270

683

814

266

507

798

純利益

13,534

3,156

2,409

3,928

4,041

3,606

純利益成長率

-12%

-15%

23%

24%

34%

流通済み株式数（希薄化後）

1,916

1,937

1,940

1,960

1,979

株式変動（前年比）

-3%

-4%

EPS（希薄化）

7.06

1.65

1.24

2.02

2.06

1.82

EPS成長率

-9%

-11%

28.99%

30%

39%

フリーキャッシュフロー

15,962

2,869

1,247

5,740

6,106

2,151

1株当たりフリーキャッシュフロー

粗利益

75.4%

74.55%

74.44%

75.37%

77.15%

76.26%

営業利益率

31.81%

30.41%

29.22%

31.93%

35.48%

35.23%

利益率

24.05%

23.35%

17.38%

27.35%

27.81%

26.54%

フリーキャッシュフロー利益率

28.37%

21.23%

8.99%

39.97%

42.03%

15.83%

EBITDA

23,298

5,337

5,601

5,949

6,411

5,940

EBITDAマージン

41.41%

39.5%

40.41%

41.43%

44.13%

43.72%

D&A による EBITDA

5,399

1,228

1,551

1,364

1,256

1,154

営業利益

17,899

4,109

4,050

4,585

5,155

4,786

営業利益率

31.81%

30.41%

29.22%

31.93%

35.48%

35.23%

実効税率

14.38%

17.79%

25.29%

6.33%

11.18%

18.1%

Follow-Up Questions

Báo cáo tài chính chính của Novartis AG là gì?



Theo báo cáo tài chính mới nhất (Form-10K), Novartis AG có tổng tài sản là $0, lợi nhuận ròng 損失 là $0

Tỷ lệ tài chính chính của NVS là gì?



Tỷ lệ thanh khoản của Novartis AG là 0, tỷ suất lợi nhuận ròng là 0, doanh thu trên mỗi cổ phiếu là $0.

Doanh thu của Novartis AG được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?



Novartis AG の最大収益セグメントは Other で、最新の利益発表における収益は 2,142,000,000 です。地域別に見ると、United States Revenue (Post-Q2 2023 Reporting) が Novartis AG の主要市場であり、収益は 23,331,000,000 です。

Novartis AG có lợi nhuận không?



いいえ, theo báo cáo tài chính mới nhất, Novartis AG có lợi nhuận ròng 損失 là $0

Novartis AG có nợ không?



いいえ, Novartis AG có nợ là 0

Novartis AG có bao nhiêu cổ phiếu đang lưu hành?



Novartis AG có tổng cộng 0 cổ phiếu đang lưu hành

Novartis AG (NVS) 財務

NVS 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

Novartis AGとは何ですか？

Novartis AG (NVS) 財務

NVS 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

Novartis AGとは何ですか？

NVS 収入

Follow-Up Questions

Báo cáo tài chính chính của Novartis AG là gì?

Tỷ lệ tài chính chính của NVS là gì?

Doanh thu của Novartis AG được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

Novartis AG có lợi nhuận không?

Novartis AG có nợ không?

Novartis AG có bao nhiêu cổ phiếu đang lưu hành?